ITEM VIEW

Serum prostate specific antigen (PSA) as surrogate for the histological diagnosis of prostate cancer

dc.contributor.authorHeyns, C. F.
dc.contributor.authorNaude, A. M.
dc.contributor.authorAhmed, G.
dc.contributor.authorStopforth, H. B.
dc.contributor.authorStellmacher, G. A.
dc.contributor.authorVisser, A. J.
dc.date.accessioned2013-01-23T11:47:03Z
dc.date.available2013-01-23T11:47:03Z
dc.date.issued2001-08
dc.identifier.citationHeyns, C. F. et al. 2001. Serum prostate specific antigen (PSA) as surrogate for the histological diagnosis of prostate cancer. South African Medical Journal, 91(8):685-689.en_ZA
dc.identifier.issn2078-5135 (online)
dc.identifier.issn0256-9574 (print)
dc.identifier.urihttp://hdl.handle.net/10019.1/73772
dc.descriptionThe original publication is available at http://www.samj.org.zaen_ZA
dc.description.abstractIntroduction. To determine whether there is a cut-off value of serum prostate-specific antigen (PSA) which can be used confidently to make the diagnosis of prostate cancer, thereby obviating the need for biopsy. Patients and methods. During the period October 1991 to March 1998 the Department of Chemical Pathology at Tygerberg Hospital performed a total of 6 733 serum PSA assays on 3 960 patients. The histopathological and clinical diagnoses of these patients were obtained from records in the departments of Anatomical Pathology, Urological Oncology and Radiation Oncology. The serum PSA levels were correlated with the histopathology reports, using different PSA cut-off values ranging from 5 to 500 ng/ml, to calculate the sensitivity, specificity, and positive and negative predictive values of each cut-off value of PSA in predicting the presence of prostate cancer.en_ZA
dc.format.extentpp. 685-689
dc.publisherHealth and Medical Publishing Group (HMPG)en_ZA
dc.subjectProstate cancer -- Diagnosisen_ZA
dc.subjectProstate specific antigens -- Diagnostic useen_ZA
dc.subjectProstate specific antigens -- Economic aspectsen_ZA
dc.subjectProstate biopsy -- Risk factorsen_ZA
dc.subjectProstate specific antigens -- Therapeutic use -- Effectivenessen_ZA
dc.titleSerum prostate specific antigen (PSA) as surrogate for the histological diagnosis of prostate canceren_ZA
dc.typeArticleen_ZA
dc.rights.holderAuthors retain copyrighten_ZA


Files in this item

Thumbnail

This item appears in the following Collection(s)

ITEM VIEW